GlobalData’s Clinical Trials Database is a comprehensive source of information on clinical trials worldwide, providing accurate and detailed intelligence to address your clinical development needs. The database covers interventional, observational and expanded access studies involving therapeutic and prophylactic interventions for a wide range of therapy areas and indications, including rare diseases.
Why choose GlobalData’s Clinical Trials Database?
– Save time and effort by gaining access to accumulated information from various sources and registries in a standardized format, reducing the need for research.
– Monitor and evaluate a product’s clinical development and use our Clinical Trial Analyzers to customize data evaluation.
– Access GlobalData’s other databases covering Pharmaceutical Products, Investigators, Companies and News, which are seamlessly integrated with the Clinical Trials Database.
– Visualize and analyze competitors’ clinical stage portfolios using the Competitive Landscape tool.
– Gain access to a 24/7 ‘Ask an Analyst Support Service’, plus research support and training.
Request a free demo
Europe: +44 20 7406 6648
North America: +1 646 395 5460
Asia-Pacific: +91 40 6616 6700
Products and Services
Clinical Trials: Enrollment Trends in Emerging Markets – South Korea
This whitepaper provides a review of Phase I to Phase IV clinical trials with a start date between January 1, 2001 and June 5, 2018, and which have a trial location in South Korea.
Clinical Trials: Enrollment Trends in Emerging Markets – India
This whitepaper provides a review of the enrollment trends of Phase I to Phase IV clinical trials that had a start date between January 1, 2001 and December 31, 2018 and a trial location in India.
Trials: Enrollment Trends in Emerging Markets – China
Brooke Wilson, Bonnie Bain, PhD & Revati Tatake, PhD, GlobalData, examine patient recruitment trends in Chinese clinical trials
Microbiome-Based Clinical Investigations
Amina Abukar, MSc, Brooke Wilson & Revati Tatake, PhD, GlobalData, examine the microbiome in clinical trials
Clinical Trials: A Round-up of 2017
Revati Tatake & Brooke Wilson, GlobalData, provide an overview of developments that arose in the clinical trial space in 2017
An Outlook for Upcoming Clinical Trials in 2017
This white paper by GlobalData provides an outlook on the clinical trial landscape for 2017
Clinical Trials Landscape in Emerging Markets: China, 2011–2015
GlobalData assess the CT landscape in China
Analysis of a 5-Year Retrospective of Terminated Clinical Trials
GlobalData document and analyze all clinical trials that have been terminated across a five year span
The Latest Trends in Clinical Investigation in Nordic Countries, 2015
GlobalData assess 2015 trends that emerged from clinical trials conducted in the Nordics
What Does Trial Success Look Like? A 5-Year Retrospective of Trials Completed in 2011–2015
GlobalData's latest white paper takes a retrospective look on the CT landscape in the last five years
Post-Brexit Fall-Out for the UK Pharma and Medical Device Industries
In its latest white paper, GlobalData assesses the implications of the Brexit vote on UK clinical research
Increasing CRO Involvement: A 10-Year Global Retrospective of Clinical Trials
Read GlobalData's White Paper focusing on the increasing influence of CROs in the clinical trial space
Clinical Trials in Asia-Pacific
GlobalData provide an overview of the CT landscape in the Asia-Pacific region
A Scorecard for 2015 Clinical Trials in Europe
Check out GlobalData's latest White Paper about Clinical Trials in Europe
Obesity Clinical Trials in 2015
The latest Whitepaper by GlobalData looks at Obesity Clinical Trials
Schizophrenia Clinical Trials – an Overview of the Last Five Years, 2011–2015
The latest Whitepaper by GlobalData looks at Clinical Trials for Schizophrenia